The marches are taking place against a backdrop of polit...

After a year of testing on its own employees, Amazon wil...

With another Senate vote scheduled at 1 a.m. on Monday, ...

Hydrosalpinx: Symptoms, fertility, and treatment

Hydrosalpinx is the name for a condition where a woman’s fallopian tube becomes blocked with fluid. Learn about how it affects fertility.
Read More

Toxic substance may yield male birth control pill

Researchers reveal how a modified form of a plant-derived compound once used as a poison could be a viable candidate for a male birth control pill.
Read More

Can beet juice help treat erectile dysfunction?

Beet juice is becoming a popular home remedy for erectile dysfunction (ED), but can it really help a man get and keep an erection? We look at the evidence.
Read More

Persian shallot ‘could help fight TB antibiotic resistance’

Properties in Persian shallots could boost the effects of antibiotic treatment, a study says.
Read More

Why you shouldn’t put off that Pap test any longer

It’s Cervical Health Awareness Month, so we turn to an important topic: the Pap test. What is it, should it scare you, and why should you get it done?
Read More

Adolescence now lasts from 10 to 24, scientists say

Delayed marriage and parenthood has pushed back perceptions of when adulthood begins, scientists say.
Read More

NHS bail-outs could become new normal, National Audit Office says

Money meant to transform services has been used to shore up finances, the National Audit Office says.
Read More

Cancer blood test ‘enormously exciting’

Scientists move nearer to one of the biggest goals in medicine – a universal blood test for cancer.
Read More

U.S. court invalidates J&J cancer drug patent, hitting UK’s BTG

NEW YORK (Reuters) – A U.S. administrative court invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc .

Read More

Snus tobacco on the rise as Norway smoking halved in a decade

OSLO (Reuters) – The share of Norwegians who smoke on a daily basis has halved in the last decade and was last year exceeded for the first time by the use of snus, a wet snuff tobacco product, Statistics Norway said on Thursday.

Read More